TIDMHLO

RNS Number : 7204W

Healthcare Locums PLC

02 February 2012

Earlier today the Company announced the appointment of Sue Bygrave as Chief Finance Officer (Designate). This press release is being reissued owing to an incorrect date in the original version of the table showing past directorships. The dates have now been corrected and the full text of the announcement is printed below.

Healthcare Locums plc

("HCL" or the "Company")

Directorate Change - Amendment

Appointment of Chief Finance Officer (Designate)

The Board of Healthcare Locums plc, a leading provider of staffing solutions in the health and social care sectors, is pleased to announce the appointment of Sue Bygrave, 46, as Chief Finance Officer (Designate), succeeding Bill Jessup, Interim Chief Finance Officer who will step down on publication of the financial accounts for the year ended 31 December 2011. Sue will formally take up her role as an Executive Director on the Board of HCL on 6 February 2012 and will assume responsibility for all accounting activity across the Group including operations in Australia.

Sue joins from Biome Technologies plc, the AIM listed bioplastics and RF (radio frequency) technology business, where she was Group Finance Director supporting an acquisition strategy whilst driving organic growth. Prior to Biome Technologies, Sue was Group Finance Director of VEGA Group plc, an organisation delivering consulting, technology and managed solutions into Aerospace, Defence and Government Markets. She was Joint Chair of the Executive Management Team that saw the repositioning of the business as an independent specialist services company prior to its acquisition by Finmeccanica in 2008.

Sue is an ACA qualified accountant and began her career with KPMG in Audit.

Peter Sullivan, Chairman of HCL, commented: "We are delighted that Sue is joining the company as Chief Finance Officer. She brings with her a wealth of experience which will be invaluable to the business as we continue to transform the organisation. We look forward to welcoming her to the Board."

Sue holds or has held directorships in the five years preceding her appointment at HCL as follows:

 
 Current directorships and   Past directorships and partnerships 
  partnerships 
--------------------------  -------------------------------------------- 
 None                        Biome Technologies plc (Jan 2009-Oct 
                              2011) 
--------------------------  -------------------------------------------- 
                             VEGA Group plc (Nov 2004-Feb 2008) 
--------------------------  -------------------------------------------- 
                             Mettoni Group plc (placed into receivership 
                              July 2002, dissolved April 2009) 
--------------------------  --------------------------------------------

There are no further disclosures to be made with regards to this appointment under paragraph (g) of Schedule 2 of the AIM Rules.

Ends

For further information please contact:

Healthcare Locums plc

Stephen Burke, Chief Executive Officer

020 7451 1451

Investec Bank plc

Gary Clarence/Patrick Robb/Daniel Adams

020 7597 5970

Pelham Bell Pottinger

David Rydell/Emma Kent/Duncan Mayall/Charlotte Offredi

020 7861 3233

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOABKBDQPBKDOBK

Healthcare Locums (LSE:HLO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Healthcare Locums Charts.
Healthcare Locums (LSE:HLO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Healthcare Locums Charts.